ANI Pharmaceuticals
ANIP
ANIP
200 hedge funds and large institutions have $975M invested in ANI Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.81% less ownership
Funds ownership: 67.78% → 66.98% (-0.81%)
91% less call options, than puts
Call options by funds: $3.41M | Put options by funds: $39.2M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
200
Holding in Top 10
–
Calls
$3.41M
Puts
$39.2M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$10.4M | |
| 3 | +$6.04M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$4.53M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$13.3M | |
| 3 | -$11.5M | |
| 4 |
SC
Stempoint Capital
New York
|
-$4.71M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.82M |